Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB1453 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	SB1453 HFLR Page 1
4		-	BOLD FACE denotes Committee Amendments. 1
	3	+	ENGR. S. B. NO. 1453 Page 1 1
5	4		2
6	5		3
7	6		4
8	7		5
9	8		6
10	9		7
11	10		8
12	11		9
13	12		10
14	13		11
15	14		12
16	15		13
17	16		14
18	17		15
19	18		16
20	19		17
21	20		18
22	21		19
23	22		20
24	23		21
25	24		22
26	25		23
27	26		24
28		-
29		-	HOUSE OF REPRESENTATIVES - FLOOR VERSION
30		-
31		-	STATE OF OKLAHOMA
32		-
33		-	2nd Session of the 59th Legislature (2024)
34	27
35	28		ENGROSSED SENATE
36	29		BILL NO. 1453 By: Rosino of the Senate
37	30
38	31		and
39	32
40	33		Newton of the House
41	34
42	35
43	36
44	37
45	38		An Act relating to the Attorney General; amending 74
46	39		O.S. 2021, Section 30.5, as amended by Section 1,
47	40		Chapter 75, O.S.L. 2022 (74 O.S. Supp. 2023, Section
48	41		30.5), which relates to definitions used in the
49	42		Political Subdivisions Opioid Abatement Grants Act ;
50	43		broadening certain definitions; removing obsolete
51	44		language; amending 74 O.S. 2021, Section 30.6, which
52	45		relates to the Oklahoma Opioid Abatement Revolving
53	46		Fund; authorizing the Office of the Attorney General
54	47		to withhold and use certain funds for certain
55	48		purposes; updating statutory reference; and providing
56	49		an effective date.
57	50
58	51
59	52
60	53
61	54		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
62	55		SECTION 1. AMENDATORY 74 O.S. 2021, Section 30.5, as
63	56		amended by Section 1, Chapter 75, O.S.L. 2022 (74 O.S. Supp. 2023,
64	57		Section 30.5), is amended to read as follows:
65	58		Section 30.5. As used in the Political S ubdivisions Opioid
66	59		Abatement Grants Act:
67	60		1. “Approved purpose” and “approved purposes” mean evidence-
68	61		based, forward-looking strategies, programming and services used to:
	62	+	a. expand the availability of tre atment for individuals
	63	+	affected by opioid use diso rders, co-occurring
	64	+	substance use disorders and mental health issues,
69	65
70		-	SB1453 HFLR Page 2
71		-	BOLD FACE denotes Committee Amendments. 1
	66	+	ENGR. S. B. NO. 1453 Page 2 1
72	67		2
73	68		3
74	69		4
75	70		5
76	71		6
77	72		7
78	73		8
79	74		9
80	75		10
81	76		11
82	77		12
83	78		13
84	79		14
85	80		15
86	81		16
87	82		17
88	83		18
89	84		19
90	85		20
91	86		21
92	87		22
93	88		23
94	89		24
95	90
96		-	a. expand the availability of tre atment for individuals
97		-	affected by opioid use diso rders, co-occurring
98		-	substance use disorders and mental health issues,
99	91		b. develop, promote and provide evidence-based opioid use
100	92		prevention strategies,
101	93		c. provide opioid use disorder and co-occurring substance
102	94		use disorder avoidance and awareness educatio n,
103	95		d. decrease the oversupply of licit and i llicit opioids,
104	96		e. support recovery from addiction services performed by
105	97		qualified and approp riately licensed providers,
106	98		f. treat opioid use, abuse and disorders including early
107	99		intervention screening, counse ling and support,
108	100		g. support individuals in treatment and recovery f rom
109	101		opioid use, abuse and disorder,
110	102		h. provide programs or services to c onnect individuals
111	103		with opioid use, abuse or disorder, or who are at ris k
112	104		of developing opioid us e disorder, co-occurring
113	105		substance use disorder and mental health i ssues, with
114	106		treatment and counseling programs and services,
115	107		i. address the needs of individu als who are involved, or
116	108		who are at risk of becoming involved, in the cr iminal
117	109		justice system due to opioid use, abuse or disorder
118	110		through programs or services in municipal and county
119	111		criminal judicial systems including prearrest and
	112	+	postarrest diversion programs, pretrial services and
	113	+	drug or recovery courts,
120	114
121		-	SB1453 HFLR Page 3
122		-	BOLD FACE denotes Committee Amendments. 1
	115	+	ENGR. S. B. NO. 1453 Page 3 1
123	116		2
124	117		3
125	118		4
126	119		5
127	120		6
128	121		7
129	122		8
130	123		9
131	124		10
132	125		11
133	126		12
134	127		13
135	128		14
136	129		15
137	130		16
138	131		17
139	132		18
140	133		19
141	134		20
142	135		21
143	136		22
144	137		23
145	138		24
146	139
147		-	postarrest diversion programs, pretrial services and
148		-	drug or recovery courts,
149	140		j. address the needs of pregnant or paren ting women with
150	141		opioid use, abuse or disorder and their families ,
151	142		k. address the needs of parents and caregivers caring for
152	143		babies with neonatal abstinence syndrome,
153	144		l. support efforts to prevent overprescribing and ensure
154	145		appropriate prescribing and dispensing of opioids,
155	146		m. support efforts to discourage or prevent misuse of
156	147		opioids including the oversupply of licit and illicit
157	148		opioids,
158	149		n. support efforts to prevent or reduce overdose deaths
159	150		or other opioid-related harms including through
160	151		increased availability and distribution of nalox one
161	152		and other drugs that treat overdoses for use by first
162	153		responders, persons who have experienced an overdose
163	154		event, families, schools, community-based service
164	155		providers, social workers and other mem bers of the
165	156		public,
166	157		o. reimburse or fund law enforcem ent and emergency
167	158		responder expenditures relating to the opioid epidemic
168	159		including costs of responding to emergency medical or
169	160		police calls for service, equipment, treatment or
170	161		response alternatives, mental health response train ing
	162	+	and training for law en forcement and emergency
	163	+	responders as to appropriate practices and precautions
171	164
172		-	SB1453 HFLR Page 4
173		-	BOLD FACE denotes Committee Amendments. 1
	165	+	ENGR. S. B. NO. 1453 Page 4 1
174	166		2
175	167		3
176	168		4
177	169		5
178	170		6
179	171		7
180	172		8
181	173		9
182	174		10
183	175		11
184	176		12
185	177		13
186	178		14
187	179		15
188	180		16
189	181		17
190	182		18
191	183		19
192	184		20
193	185		21
194	186		22
195	187		23
196	188		24
197	189
198		-	and training for law en forcement and emergency
199		-	responders as to appropriate practices and precautions
200	190		when dealing with opioids or individuals who are at
201	191		risk of opioid overdose or death,
202	192		p. reimburse attorney fees and allowable expenses
203	193		directly related to opioid litigation incurred as part
204	194		of legal services agreements entered into before May
205	195		21, 2020,
206	196		q. support efforts to provide leadership, planning and
207	197		coordination to abate the opioid epidemic throu gh
208	198		activities, programs o r strategies for preventi on and
209	199		recovery models including regional intergovernmental
210	200		efforts and not-for-profit agency support,
211	201		r. support education of youths regarding the dangers of
212	202		opioid use, abuse and addiction,
213	203		s. fund training relative to any approv ed purpose,
214	204		t. monitor, surveil and evaluate opioid use, abuse or
215	205		disorder, or
216	206		u. provide opioid abatement as identified by the Oklahoma
217	207		Opioid Abatement Board as consistent with t he purpose
218	208		of the Political Subdivisions Opioid Abatement Grants
219	209		Act.
220	210		Provided that, such strategies, programming and services occurred on
221	211		or after January 1, 2015.
222	212
223		-	SB1453 HFLR Page 5
224		-	BOLD FACE denotes Committee Amendments. 1
	213	+	ENGR. S. B. NO. 1453 Page 5 1
225	214		2
226	215		3
227	216		4
228	217		5
229	218		6
230	219		7
231	220		8
232	221		9
233	222		10
234	223		11
235	224		12
236	225		13
237	226		14
238	227		15
239	228		16
240	229		17
241	230		18
242	231		19
243	232		20
244	233		21
245	234		22
246	235		23
247	236		24
248	237
249	238		Approved purpose also includes any approved uses as authorized
250	239		by opioid-related settlement agreeme nts in which the State of
251	240		Oklahoma is a litigant or participant ;
252	241		2. “Board” means the Oklahoma Opioid Abatement Board;
253	242		3. “Eligible participant ” means any political subdiv ision
254	243		impacted by the opioid crisis ;
255	244		4. “Nonapproved purpose” and “nonapproved purposes ” mean
256	245		strategies, programming and services not falling within the
257	246		definition of approved purpose or approved purposes as defined in
258	247		this section;
259	248		5. “Opioid funds” means all monetary amounts obtained through a
260	249		settlement or judgment by the Attorney General on beh alf of this
261	250		state related to opioid litigation invol ving pharmaceutical supply
262	251		chain participants including the Purdue Political Subdivisions Fund
263	252		but excluding all other funds received pursuant to the Purdue
264	253		Settlement Agreement;
265	254		6. “Opioid grant awards” means grants funded from the Oklahoma
266	255		Opioid Abatement Revolving Fund, aw arded pursuant to the provisions
267	256		of the Political Subdivisions Opioid Abatement Grants Act;
268	257		7. “Pharmaceutical supply chain ” means the process and channels
269	258		through which controlled substances are manufactured, marketed,
270	259		promoted, distributed or dispensed;
271	260
272		-	SB1453 HFLR Page 6
273		-	BOLD FACE denotes Committee Amendments. 1
	261	+	ENGR. S. B. NO. 1453 Page 6 1
274	262		2
275	263		3
276	264		4
277	265		5
278	266		6
279	267		7
280	268		8
281	269		9
282	270		10
283	271		11
284	272		12
285	273		13
286	274		14
287	275		15
288	276		16
289	277		17
290	278		18
291	279		19
292	280		20
293	281		21
294	282		22
295	283		23
296	284		24
297	285
298	286		8. “Pharmaceutical supply chain participant” means any entity
299	287		that engages in or has engaged in the manufacture, marketing,
300	288		promotion, distribution or dispensing of an opioid analgesic;
301	289		9. “Political subdivision ” and “political subdivisions” have
302	290		the same meaning as provided in subparagraphs a, b, c and d of
303	291		paragraph 11 of Section 152 of Titl e 51 of the Oklahoma Statutes .
304	292		Political subdivision also means the board of regents or board of
305	293		trustees of an institution of higher education within The Okla homa
306	294		State System of Higher Education ;
307	295		10. “Purdue Political Subdivision Fund” means the Twelve
308	296		Million Five Hundred Thousand Dollars ($12,500,000.0 0) plus any
309	297		interest accrued thereon received from the Revive Oklahoma Health
310	298		Foundation consisting of funds received from the Purdue Settlement
311	299		Agreement designed for distribu tion to political subdivisi ons which
312	300		have executed a release of legal claims as required by the Purdue
313	301		Settlement Agreement; and
314	302		11. “Purdue Settlement Agreement” means the settlement
315	303		agreement entered into by this state and Purdue Pharma L.P., Purdue
316	304		Pharma, Inc. and the Purdue Fr ederick Company on March 26, 2019, a nd
317	305		approved by the Court on April 2, 2019.
318	306		SECTION 2. AMENDATORY 74 O.S. 2021, Section 30.6 , is
319	307		amended to read as follows:
320	308		Section 30.6. A. There is hereby created in the State Treasury
321	309		a revolving fund for the Office of the Attorney General to be
322	310
323		-	SB1453 HFLR Page 7
324		-	BOLD FACE denotes Committee Amendments. 1
	311	+	ENGR. S. B. NO. 1453 Page 7 1
325	312		2
326	313		3
327	314		4
328	315		5
329	316		6
330	317		7
331	318		8
332	319		9
333	320		10
334	321		11
335	322		12
336	323		13
337	324		14
338	325		15
339	326		16
340	327		17
341	328		18
342	329		19
343	330		20
344	331		21
345	332		22
346	333		23
347	334		24
348	335
349	336		designated the “Oklahoma Opioid Abatement Revolving Fun d”. The fund
350	337		shall be a continuing fund, not su bject to fiscal year limitations,
351	338		and shall consist of all opioid funds obtained through a settl ement
352	339		or judgment by the Attorney General on behalf of the State of
353	340		Oklahoma related to opioid litigation involving pharmaceutical
354	341		supply chain participa nts:
355	342		1. Designated for deposit in the fund; or
356	343		2. Appropriated to the fund by the Legislature.
357	344		B. Provided that the Purdue Political Subdivisions Fund shall
358	345		be maintained in a segregated State Treasury fund withi n the
359	346		Oklahoma Opioid Abatement Revolving Fund, and that the Purdue
360	347		Political Subdivisions Fun d shall not be commingled with other
361	348		opioid funds deposited in or appropriated to the Oklahoma Opioid
362	349		Abatement Revolving Fund.
363	350		C. To the extent allowed by any settlement or judgment relating
364	351		to opioid litigation involving pharmaceutical supply chain
365	352		participants, the Office of the Attorney General may withhold not
366	353		more than five percent (5%) of the funds received by the Oklahoma
367	354		Opioid Abatement Revolving Fund for the st aff and administrative
368	355		support required by Section 30.7 of this title. Such funds may also
369	356		be used to research and evaluate the effectiveness of grants
370	357		disbursed by the Oklahoma Opioid Abatement Board .
371	358		D. All monies accruing to the credit of the fund are hereby
372	359		appropriated and may be b udgeted and expended by the Attorney
373	360
374		-	SB1453 HFLR Page 8
375		-	BOLD FACE denotes Committee Amendments. 1
	361	+	ENGR. S. B. NO. 1453 Page 8 1
376	362		2
377	363		3
378	364		4
379	365		5
380	366		6
381	367		7
382	368		8
383	369		9
384	370		10
385	371		11
386	372		12
387	373		13
388	374		14
389	375		15
390	376		16
391	377		17
392	378		18
393	379		19
394	380		20
395	381		21
396	382		22
397	383		23
398	384		24
399	385
400	386		General for the purpose of funding opioid grant awards as authoriz ed
401	387		by this act the Political Subdivisions Opioid Abatement Grants Act.
402	388		SECTION 3. This act shall become effective November 1, 2024.
	389	+	Passed the Senate the 20th day of February, 2024.
403	390
404		-	COMMITTEE REPORT BY: COMMITTEE ON GENERAL GOVERNMENT, dated
405		-	04/09/2024 - DO PASS.
	391	+
	392	+
	393	+	Presiding Officer of the Senate
	394	+
	395	+
	396	+	Passed the House of Representatives the ____ day of __________,
	397	+	2024.
	398	+
	399	+
	400	+
	401	+	Presiding Officer of the House
	402	+	of Representatives
	403	+